The Latest Breaking News from Medtronic

Medtronic reported lighter-than-expected sales and earnings for its fiscal fourth quarter on Thursday, and MDT stock tumbled.

Medtronic Plc's (NYSE:MDT) Q4 FY22 sales of $8.09 billion decreased 1% Y/Y on a reported basis but increased 1% organically, missing the consensus of $8.42 billion. The company has forecasted Q4 organic revenue growth of approximately 5.5%. Q4 adjusted EPS of $1.52 increased 2%, missing the analyst consensus of $1.56. Medtronic's heart device…

Acutus Medical Inc (NASDAQ:AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The Company has also agreed to sell its left-heart access portfolio to Medtronic plc (NYSE:MDT).  The combination of these two transactions, taken together with the Company’s recently completed restructuring,…

Growing demand from an aging population to track their diseases and increased focus on critical surgical procedures with lesser COVID-19 pressures on hospitals make the medical devices industry’s prospects bright. Moreover, the integration of emerging technologies and continued innovations should drive the industry’s growth. Therefore, prominent players in this space,…

Medtronic Plc (NYSE:MDT) is recalling the Harmony Delivery Catheter, part of the Transcatheter Pulmonary Valve (TPV), due to the possibility that the bond holding the capsule at the end of the delivery catheter may break during a procedure.  Harmony TPV System is used to treat a leaky native or surgically repaired right…

Needham published a report that pointed to previous comments from Medtronic plc's (NYSE: MDT) management that indicate the potential for changes in the coming year, with a spinoff of a large business considered an option.

As supply chain constraints continue to squeeze health care stocks, one analyst suggested Monday to look for "ports in storms."

: Major stock indices appear heading for weekly gains with the Fed’s first interest rate hike digested easily by investors. However, the market is expected to remain under pressure in the near term. So, because wide-moat companies generally do well in these market conditions, we think cheap wide-moat stocks Bristol-Myers…

Medtronic plc (NYSE:MDT) announced final findings from a study that confirmed the effectiveness of the GI Genius intelligent endoscopy module.  GI Genius uses AI to aid in detecting colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer (CRC).  The study published in Gastroenterology found that the use of GI Genius in conjunction with…